175 related articles for article (PubMed ID: 32532646)
1. Anesthesia Exposure during Therapy Predicts Neurocognitive Outcomes in Survivors of Childhood Medulloblastoma.
Jacola LM; Anghelescu DL; Hall L; Russell K; Zhang H; Wang F; Peters JB; Rossi M; Schreiber JE; Gajjar A
J Pediatr; 2020 Aug; 223():141-147.e4. PubMed ID: 32532646
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma.
Partanen M; Anghelescu DL; Hall L; Schreiber JE; Rossi M; Gajjar A; Jacola LM
Eur J Cancer; 2021 May; 148():103-111. PubMed ID: 33743477
[TBL] [Abstract][Full Text] [Related]
3. Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study.
Palmer SL; Armstrong C; Onar-Thomas A; Wu S; Wallace D; Bonner MJ; Schreiber J; Swain M; Chapieski L; Mabbott D; Knight S; Boyle R; Gajjar A
J Clin Oncol; 2013 Oct; 31(28):3494-500. PubMed ID: 23980078
[TBL] [Abstract][Full Text] [Related]
4. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
Edelstein K; Spiegler BJ; Fung S; Panzarella T; Mabbott DJ; Jewitt N; D'Agostino NM; Mason WP; Bouffet E; Tabori U; Laperriere N; Hodgson DC
Neuro Oncol; 2011 May; 13(5):536-45. PubMed ID: 21367970
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
6. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma.
Yoo HJ; Kim H; Park HJ; Kim DS; Ra YS; Shin HY
J Korean Med Sci; 2016 Nov; 31(11):1726-1734. PubMed ID: 27709849
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
Krull KR; Brinkman TM; Li C; Armstrong GT; Ness KK; Srivastava DK; Gurney JG; Kimberg C; Krasin MJ; Pui CH; Robison LL; Hudson MM
J Clin Oncol; 2013 Dec; 31(35):4407-15. PubMed ID: 24190124
[TBL] [Abstract][Full Text] [Related]
10. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
[TBL] [Abstract][Full Text] [Related]
11. Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort.
Phillips NS; Howell CR; Lanctot JQ; Partin RE; Pui CH; Hudson MM; Robison LL; Krull KR; Ness KK
Cancer; 2020 Feb; 126(3):640-648. PubMed ID: 31631333
[TBL] [Abstract][Full Text] [Related]
12. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
[TBL] [Abstract][Full Text] [Related]
14. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive deficits in medulloblastoma survivors and white matter loss.
Mulhern RK; Reddick WE; Palmer SL; Glass JO; Elkin TD; Kun LE; Taylor J; Langston J; Gajjar A
Ann Neurol; 1999 Dec; 46(6):834-41. PubMed ID: 10589535
[TBL] [Abstract][Full Text] [Related]
16. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.
Hardy KK; Bonner MJ; Willard VW; Watral MA; Gururangan S
Psychooncology; 2008 Nov; 17(11):1157-61. PubMed ID: 18636431
[TBL] [Abstract][Full Text] [Related]
17. Cognitive consequences of the treatment of medulloblastoma among children.
Saury JM; Emanuelson I
Pediatr Neurol; 2011 Jan; 44(1):21-30. PubMed ID: 21147383
[TBL] [Abstract][Full Text] [Related]
18. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.
Schreiber JE; Gurney JG; Palmer SL; Bass JK; Wang M; Chen S; Zhang H; Swain M; Chapieski ML; Bonner MJ; Mabbott DJ; Knight SJ; Armstrong CL; Boyle R; Gajjar A
Neuro Oncol; 2014 Aug; 16(8):1129-36. PubMed ID: 24497405
[TBL] [Abstract][Full Text] [Related]
19. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.
Mulhern RK; Palmer SL; Reddick WE; Glass JO; Kun LE; Taylor J; Langston J; Gajjar A
J Clin Oncol; 2001 Jan; 19(2):472-9. PubMed ID: 11208841
[TBL] [Abstract][Full Text] [Related]
20. The Neurological Predictor Scale: A predictive tool for long-term core cognitive outcomes in survivors of childhood brain tumors.
Taiwo Z; Na S; King TZ
Pediatr Blood Cancer; 2017 Jan; 64(1):172-179. PubMed ID: 27566994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
